SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001412071-26-000006
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+36.82K
Net shares
Net buyer
$7.1K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
36.82K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36.82K
Price / share
$0.19
Trade value
$7.07K
% of position
204.2%
6/30/2026
18.03K→54.85K
Total
Net shares
+36.82K
Net value
$7.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | A · Award | +36.82K | $0.19 | $7.07K | 204.2% | 18.03K | 54.85K |
| Total | +36.82K | $7.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20.88K
Total
20.88K indirect20.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.88K | Indirect |
| Total | 20.88K | 20.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported